SynthesisMedicine2019

Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review.

Alessandro Sciarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.